期刊文献+

A型肉毒毒素保护性抗原的基因修饰及高效表达 被引量:1

Modification and High Level Expression of Protective Antigen Fragment of Botulinum Neurotoxin Serotype A
下载PDF
导出
摘要 在A型肉毒毒素保护性抗原基因初步表达的基础上 ,为提高表达水平 ,依据EMBL的DNA数据库中A型肉毒毒素基因全序列 ,重新设计上游引物 ,通过修饰基因片段N端 ,保持氨基酸序列不变 ,从已获得的A型肉毒毒素与靶细胞起结合作用的重链C端基因中 ,扩增小的突变基因 ,克隆入pGEM T载体进行测序 ,并以pBV2 2 0为表达载体构建重组表达质粒 ,在大肠杆菌中实现高效表达。结果表明 ,重组表达产物占全菌蛋白的 4 0 % ,酶联检测重组表达产物具有特异结合活性。A型肉毒毒素保护性抗原基因的高效表达 。 Designed a pair of primers through modifying N terminal bases(5bps) of gene after ATG but not changing amino acid, and amplified a smaller mutated gene sequnce (468bp) containing two protective antigenic determinants from pBlue BoNTaHc, N terminal codon of mutated gene fragment is changed from low to high frenqence in E.coli . Mutated gene was ligated into pGEM T vector and sequenced, then, cloned into a expression plasmid pBV220 As a result, cloned gene was expressed in insoluble form by temperature inducing (from 30℃to 42℃)in E.coli ,.Expression pruduct is 40% of total proteins and is of specific binding activity to antibody in ELISA.The successful modification and high level expression of protective fragment of botulinum neurotoxin serotype A(BoNTaHc468) gene is conducive to further study on antitoxin and vaccine.
作者 王慧 荫俊
出处 《生物工程学报》 CAS CSCD 北大核心 2004年第4期544-547,共4页 Chinese Journal of Biotechnology
基金 全军医药卫生科研基金资助 (No .98M13 6和 0 1MB0 5 9)~~
关键词 A型肉毒毒素 保护性抗原 基因修饰 高效表达 botulinum neurotoxin serotype A, protective antigen, modification, expression
  • 相关文献

参考文献2

二级参考文献10

  • 1[1]THOMAS B,HISAO K,MICAELA W,et al. The complete sequence of b otulinum neurotoxin type A and comprison with other Clostridial neurotoxins[J ]. The Journal of Biological Chemistry, 1990, 265(16):9153-9158.
  • 2[2]WILLEMS A,EAST A K, LAWSON P A,et al. Sequence ofthe gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botuli num: comprison with other clostridial neurotoxins[J].Res Microbiol,1993,14 4:547-556.
  • 3[3]MICHAEL A C, JENNIFER M C, DOUGLAS R B, etal.Protective vaccination wi th a recombinant fragment of clostridium botulinum neurotoxin serotype A expre ssed from a synthetic gene in Escherichia coli[J]. Infection and Imm unity,1995,63(7):2738-2742.
  • 4[4]EMANUEL P A,DANG J,GEBHARDT J S, et al. Re-combinant antibodies:a new reagent for biological agent detection[J ].Biosens Bioelectron,2000,14(10-11):751-759.
  • 5[5]CLAYTON J,MIDDLEBROOK J L.Vaccination of mice withDNA encoding a large fragment of botulinum neurotoxin serotype A[J].Vaccine,2000,18(17):1855-18 62.
  • 6[6]MARK T,DERTAUGH W, MICHAEL W W.Mapping of protective and c ross-reac tive domains ofthe type A neurotoxin of Clostridium botulinum[J]. Vaccine, 1996,14(16):1538.
  • 7[7]BAVARI S, DOROTHY D P,EDNA R T,et al. Identifyingthe principle prote ctive antigenic determinants of type A botulinum neurotoxin[J].Vaccine,1998, 16(19):1850-1856.
  • 8张智清,病毒学报,1988年,4卷,97页
  • 9侯云德,病毒基因工程的原理与方法,1985年
  • 10张德震,病毒学报

共引文献179

同被引文献17

  • 1Monteccucco C,Schiavo G.Mechanism of action of tetanus and botulinum neurotoxins.Mol Microbiol,1994,13(1):1-8.
  • 2Montecucco C,Schiavo G,Tugnoli V,et al.Botulinum neurotoxins:mechanism of action and therapeutic applications.Mol Med Today,1996,2(10):418-424.
  • 3Schiavo G,Matteoli M,Montecucco C.Neurotoxins affecting neuroexocytosis.Physiol Rew,2000,80(2):717-766.
  • 4Turton K,Chaddock JA,Acharya KR.Botulinum and tetanus neurotoxtins:structure,function and therapeutic utility.Trends Biochem Sci,2002,27(11):552-558.
  • 5Byrne MP,Smith LA.Development of vaccines for prevention of botulism.Biochimie,2000,82(9-10):955-966.
  • 6LaPenotiere HF,Clayton MA,Middlebrook JL.Expression of a large nontoxic fragment of botulinum neurotoxin senotype A and its use as a immunogen.Toxicon,1995,33(10):1383-1386.
  • 7Clayton MA,Clayton JM,Brown DR,et al.Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli.Infect Immun,1995,63(7):2728-2742.
  • 8Woodward LA,Arimitsu H,Hirst R,et al.Expression of Hc subunits from clostridium botulinum type C and D and their evaluation as candidate vaccine antigens in mice.Infect Immun,2003,71(5):2941-2944.
  • 9Holley JL,Mike Elmore,Margaret Mauchline,et al.Cloning,expression and evaluation sub-unit vaccine against clostridium type F toxin.Vaccine,2001,19(2-3):288-297.
  • 10Smith LA.Development of recombinant vaccines for botulinum toxin.Toxicon,1998,36(11):1539-1548.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部